** Biotech group Oxford Nanopore Technologies ONT.L up as much as 5.7% at 115.9p
** Gene sequencing specialist is now "exposed" to acquisition, CEO and co-founder Gordon Sanghera told FT
** ONT's shares have lost 85% since its peak in 2021
** "Bankers have said it could be attractive to one of the big diagnostics specialists, such as Thermo Fisher Scientific TMO.N or Danaher DHR.N," FT report adds
** As of last close, stock down ~15% this year
(Reporting by Radhika Anilkumar in Bengaluru)
((Radhika.Anilkumar@thomsonreuters.com;))